The American Heart Association Announced the RPM Program for Heart Failure Announcement The American Heart Association introduced an RPM (remote patient monitoring) program that enables cardiac care for heart failure patients at home after hospitalization. The American Heart Association Connecte...
Resilient Medical Corp made its Place in the Competitive Jumpstart Trailblazer Health-tech Accelerator Announcement The Resilient Medical Corp, the leading manufacturer and developer of an excellent implantable medical device that diminishes risk and seamlessly heals breast cancer patients, reta...
India and Taiwan Have a Chance to Boost their Health-tech Partnership Announcement Recently, Taiwan has been a topic of discussion in the healthcare industry, with a focus on medical innovation and wellness through its top initiatives, such as ‘Go healthy with Taiwan 2025’, which has...
Australian Health Tech Startup’s New AI Hack for Vets Announcement The Australian health tech startup Heidi Health has headed into the pet area to introduce and deliver its AI medical scribe across vet clinics and emergency animal hospitals. This is the best thoughtful health-tech idea rev...
According to Precedence Research, the global healthcare chatbots market size accounted for USD 1.49 billion in 2025 and is estimated to rise from USD 1.85 billion in 2026 to nearly USD 10.26 billion by 2034, growing at a double-digit CAGR of 23.92% from 2025 to 2034. This market is rising due to dig...
PDS Biotech’s Survival Data and Phase 2 Trial in Head and Neck Cancer Announcement The PDS biotechnology corporation, a leading late-stage immunotherapy company, aims to transform the ability of the immune system to kill and target cancers, proudly announced final excellent survival data f...
Varian Enrollment and Treatment Completion for Thoracic Bone Metastases Announcement Varian, a leading Siemens Healthineers company, completed enrollment and treatment in the FAST-02, a flash radiotherapy clinical trial for the treatment of symptomatic bone metastases in the thorax. The FAST-02 ...
AbbVie Prepared an Agreement to Acquire Gilgamesh Pharmaceuticals Announcement AbbVie and Gilgamesh Pharmaceuticals Inc. introduced their definitive agreement, claiming that AbbVie will acquire Gilgamesh’s popular investigational candidate, which is currently under clinical development for...
Drugmakers Fixing Technological Risks Pros and Cons of Adopting Technology in Healthcare Pharmas speed in adopting artificial intelligence is transforming manufacturing. Pharmas move to enhance the success rates, various variables led to the discovery of AI across the vast manufacturing chain, w...
Devonians Business Updates and Additional Details on the Last Declared Private Placement Announcement Devonian Health Group Inc., a leading clinical-stage corporation targeting the developing of different solutions for inflammatory disease, with the following corporate updates, including advance...
